Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cary O Harding

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Molecular Genetics and Metabolism|October 5, 2011
Up to date knowledge on different treatment strategies for phenylketonuriaAmaya Bélanger-Quintana, Alberto Burlina, Cary O Harding, et al.
Human Gene Therapy|August 1, 2019
State-of-the-Art 2019 on Gene Therapy for PhenylketonuriaHiu Man Grisch-Chan, Gerald Schwank, Cary O Harding, et al.
The Journal of Gene Medicine|November 6, 2003
Expression of phenylalanine hydroxylase (PAH) in erythrogenic bone marrow does not correct hyperphenylalaninemia in Pah(enu2) miceCary O Harding, Mark Neff, Kelly Jones, et al.
Molecular Genetics and Metabolism Reports|May 19, 2020
Nutrient intake, body composition, and blood phenylalanine control in children with phenylketonuria compared to healthy controlsMelissa Sailer, Gabriela Elizondo, Julie Martin, et al.
Molecular Genetics and Metabolism Reports|January 21, 2020
Discontinuation of Pegvaliase therapy during maternal PKU pregnancy and postnatal breastfeeding: A case reportFran Rohr, Amy Kritzer, Cary O Harding, et al.
Molecular Genetics and Metabolism|September 15, 2020
Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPDGabriela Elizondo, Dietrich Matern, Jerry Vockley, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Complete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantationAnne Vonada, Leslie Wakefield, Michael Martinez, et al.
Human Mutation|January 3, 2013
Molecular basis of two-exon skipping (exons 12 and 13) by c.1248+5g>a in OXCT1 gene: study on intermediates of OXCT1 transcripts in fibroblastsTomohiro Hori, Toshiyuki Fukao, Keiko Murase, et al.
Hepatology (Baltimore, Md.)|October 12, 2023
Complete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantationAnne Vonada, Leslie Wakefield, Michael Martinez, et al.
Molecular Genetics and Metabolism Reports|November 24, 2022
Reinstitution of pegvaliase therapy during lactationFrances Rohr, Ann Wessel, Cary O Harding, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Molecular Genetics and Metabolism|October 5, 2011
Up to date knowledge on different treatment strategies for phenylketonuriaAmaya Bélanger-Quintana, Alberto Burlina, Cary O Harding, et al.
Human Gene Therapy|August 1, 2019
State-of-the-Art 2019 on Gene Therapy for PhenylketonuriaHiu Man Grisch-Chan, Gerald Schwank, Cary O Harding, et al.
The Journal of Gene Medicine|November 6, 2003
Expression of phenylalanine hydroxylase (PAH) in erythrogenic bone marrow does not correct hyperphenylalaninemia in Pah(enu2) miceCary O Harding, Mark Neff, Kelly Jones, et al.
Molecular Genetics and Metabolism Reports|May 19, 2020
Nutrient intake, body composition, and blood phenylalanine control in children with phenylketonuria compared to healthy controlsMelissa Sailer, Gabriela Elizondo, Julie Martin, et al.
Molecular Genetics and Metabolism Reports|January 21, 2020
Discontinuation of Pegvaliase therapy during maternal PKU pregnancy and postnatal breastfeeding: A case reportFran Rohr, Amy Kritzer, Cary O Harding, et al.
Molecular Genetics and Metabolism|September 15, 2020
Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPDGabriela Elizondo, Dietrich Matern, Jerry Vockley, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Complete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantationAnne Vonada, Leslie Wakefield, Michael Martinez, et al.
Human Mutation|January 3, 2013
Molecular basis of two-exon skipping (exons 12 and 13) by c.1248+5g>a in OXCT1 gene: study on intermediates of OXCT1 transcripts in fibroblastsTomohiro Hori, Toshiyuki Fukao, Keiko Murase, et al.
Hepatology (Baltimore, Md.)|October 12, 2023
Complete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantationAnne Vonada, Leslie Wakefield, Michael Martinez, et al.
Molecular Genetics and Metabolism Reports|November 24, 2022
Reinstitution of pegvaliase therapy during lactationFrances Rohr, Ann Wessel, Cary O Harding, et al.
Pageof 12